| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 81.544 | 90.177 | 92.740 | 86.139 | 104.924 | 93.277 | 75.568 | 80.415 | 81.477 | 126.027 |
| Total Income - EUR | 82.156 | 90.248 | 93.642 | 86.328 | 104.965 | 93.277 | 75.568 | 80.415 | 81.477 | 126.028 |
| Total Expenses - EUR | 61.458 | 65.761 | 65.209 | 67.287 | 59.954 | 55.035 | 50.370 | 61.724 | 65.642 | 110.290 |
| Gross Profit/Loss - EUR | 20.698 | 24.487 | 28.432 | 19.041 | 45.011 | 38.241 | 25.198 | 18.691 | 15.835 | 15.737 |
| Net Profit/Loss - EUR | 17.291 | 23.584 | 27.496 | 18.177 | 43.961 | 37.545 | 24.442 | 17.886 | 15.020 | 12.328 |
| Employees | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 |
Check the financial reports for the company - Oftalmo-Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 45.666 | 43.289 | 38.504 | 43.507 | 40.295 | 37.456 | 39.527 | 35.761 | 35.085 | 31.045 |
| Current Assets | 7.344 | 18.983 | 19.819 | 24.610 | 33.507 | 31.641 | 42.075 | 18.193 | 33.431 | 51.040 |
| Inventories | 3.006 | 4.220 | 6.842 | 4.692 | 5.472 | 3.521 | 6.981 | 3.590 | 4.297 | 4.394 |
| Receivables | 173 | 2.971 | 0 | 0 | 706 | 0 | 738 | 0 | 0 | 4 |
| Cash | 4.164 | 11.792 | 12.977 | 19.918 | 27.329 | 28.119 | 34.356 | 14.603 | 29.133 | 46.642 |
| Shareholders Funds | 49.936 | 50.243 | 53.704 | 43.904 | 69.190 | 62.295 | 78.192 | 46.882 | 61.760 | 73.743 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 3.397 | 12.335 | 4.739 | 24.331 | 4.612 | 6.920 | 3.525 | 7.071 | 6.755 | 8.492 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Oftalmo-Med Srl